IMPELLA

IMPELLA® cardiogenic shock extracorporeal membrane oxygenation mechanical circulatory support

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
14 Feb 2021
Historique:
received: 21 01 2021
revised: 09 02 2021
accepted: 10 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

Mechanical circulatory support (MCS) devices are effective tools in managing refractory cardiogenic shock (CS). Data comparing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and IMPELLA

Identifiants

DOI: 10.3390/jcm10040759 PMID: 33672792 PMC: PMC7918655
pubmed: 33672792
pii: jcm10040759
doi: 10.3390/jcm10040759
pmc: PMC7918655
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Res Cardiol. 2020 Nov 13;:
pubmed: 33185749
ASAIO J. 2019 Mar/Apr;65(3):219-226
pubmed: 29734259
J Heart Lung Transplant. 2020 Aug;39(8):735-750
pubmed: 32386998
JACC Cardiovasc Interv. 2020 May 25;13(10):1182-1193
pubmed: 32438988
Arch Cardiovasc Dis. 2018 Oct;111(10):601-612
pubmed: 29903693
Eur J Heart Fail. 2020 Apr;22(4):664-672
pubmed: 32078218
Eur Heart J. 2019 Aug 21;40(32):2671-2683
pubmed: 31274157
Circulation. 2020 Dec;142(22):2095-2106
pubmed: 33032450
Circulation. 2018 Feb 27;137(9):961-972
pubmed: 29483172
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
ASAIO J. 2018 Nov/Dec;64(6):708-714
pubmed: 29240628
Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(2):164-172
pubmed: 31353918
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Am Coll Cardiol. 2014 Oct 7;64(14):1407-15
pubmed: 25277608
JAMA. 2020 Feb 25;323(8):734-745
pubmed: 32040163
J Am Heart Assoc. 2019 May 7;8(9):e012171
pubmed: 31041870
EuroIntervention. 2019 Feb 08;14(15):e1585-e1592
pubmed: 30418160
Circ Heart Fail. 2020 Mar;13(3):e005853
pubmed: 32164431
Am J Cardiol. 2017 Mar 15;119(6):845-851
pubmed: 28040188
Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):329-337
pubmed: 30406678
Circ Heart Fail. 2018 Sep;11(9):e004905
pubmed: 30354364
JACC Heart Fail. 2018 Dec;6(12):1035-1043
pubmed: 30497643
Curr Vasc Pharmacol. 2018;16(5):418-426
pubmed: 29345584
J Thorac Cardiovasc Surg. 2011 Jul;142(1):60-5
pubmed: 20880553

Auteurs

Guillaume Schurtz (G)

Cardiac Intensive Care Unit, Heart and Lung Institute, CHU Lille, 59000 Lille, France.
Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Coeur Poumon, Cardiology, 59000 Lille, France.

Natacha Rousse (N)

Department of Cardiac Surgery, Institut Cœur Poumon, CHU Lille, INSERM U1011, Institut Pasteur de Lille, Université de Lille, 59000 Lille, France.

Ouriel Saura (O)

Cardiac Intensive Care Unit, Heart and Lung Institute, CHU Lille, 59000 Lille, France.
ORCID: 0000-0002-3565-3509

Vincent Balmette (V)

Cardiac Intensive Care Unit, Heart and Lung Institute, CHU Lille, 59000 Lille, France.

Flavien Vincent (F)

Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Coeur Poumon, Cardiology, 59000 Lille, France.

Nicolas Lamblin (N)

Cardiac Intensive Care Unit, Heart and Lung Institute, CHU Lille, 59000 Lille, France.
Heart and Lung Institute, University Hospital of Lille, Institut Pasteur of Lille, Inserm U1011 and FACT (French Alliance for Cardiovascular Trials), F-75000 Paris, France.

Sina Porouchani (S)

Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Coeur Poumon, Cardiology, 59000 Lille, France.

Basile Verdier (B)

Cardiac Intensive Care Unit, Heart and Lung Institute, CHU Lille, 59000 Lille, France.

Etienne Puymirat (E)

Department of Cardiology, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, 75015 Paris, France.

Emmanuel Robin (E)

Department of Cardiac Surgery, Institut Cœur Poumon, CHU Lille, INSERM U1011, Institut Pasteur de Lille, Université de Lille, 59000 Lille, France.

Eric Van Belle (E)

Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Coeur Poumon, Cardiology, 59000 Lille, France.

André Vincentelli (A)

Department of Cardiac Surgery, Institut Cœur Poumon, CHU Lille, INSERM U1011, Institut Pasteur de Lille, Université de Lille, 59000 Lille, France.

Nadia Aissaoui (N)

Department of Critical Care Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou (HEGP), Université Paris-Descartes, 75015 Paris, France.

Cédric Delhaye (C)

Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Coeur Poumon, Cardiology, 59000 Lille, France.

Clément Delmas (C)

INSERM UMR-1048, Intensive Cardiac Care Unit, Rangueil University Hospital, 31400 Toulouse, France.
ORCID: 0000-0001-9180-9128

Alessandro Cosenza (A)

Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Coeur Poumon, Cardiology, 59000 Lille, France.

Laurent Bonello (L)

Cardiology Department, Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), 13015 Marseille, France.
Centre for CardioVascular and Nutrition Research (C2VN), Aix-Marseille Univ, INSERM 1263, INRA 1260, Hopital Nord, 13015 Marseille, France.

Francis Juthier (F)

Department of Cardiac Surgery, Institut Cœur Poumon, CHU Lille, INSERM U1011, Institut Pasteur de Lille, Université de Lille, 59000 Lille, France.

Mouhamed Djahoum Moussa (MD)

Department of Cardiac Surgery, Institut Cœur Poumon, CHU Lille, INSERM U1011, Institut Pasteur de Lille, Université de Lille, 59000 Lille, France.

Gilles Lemesle (G)

Cardiac Intensive Care Unit, Heart and Lung Institute, CHU Lille, 59000 Lille, France.
Heart and Lung Institute, University Hospital of Lille, Institut Pasteur of Lille, Inserm U1011 and FACT (French Alliance for Cardiovascular Trials), F-75000 Paris, France.

Classifications MeSH